Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is tightening regulatory oversight through mandatory clinical trial training, blacklisting non-compliant foreign suppliers, and placing certain local products on watchlist, while also expanding its pharmacist reserve corps. For Nigerian SMBs in pharmaceuticals, healthcare, and related distribution, this means stricter compliance requirements and heightened scrutiny of supply chains. Businesses should verify supplier legitimacy, ensure staff training, and monitor NAFDAC alerts to avoid regulatory penalties.
Pharmaceuticals
Healthcare
Importation and Distribution
Clinical Research
Food and Drug Retail
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations
NAFDAC
NAFDAC and NHREC have rescheduled mandatory training on clinical trial regulations for stakeholders involved in clinical research in Nigeria.
SMBs involved in clinical trials, including contract research organizations and pharmaceutical sponsors, must ensure their staff attend the training to remain compliant with regulatory requirements.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, prohibiting importation, distribution, or sale in Nigeria.
Importers, distributors, and retailers must immediately stop dealing with Ayrtons Saunders Ltd products and verify their supply chains to avoid sanctions.
Public Alert No. 043/2026: NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation.
Retailers, PPMVs, and healthcare institutions should exercise caution and may need to quarantine or recall these products, pending investigation outcomes.
Inauguration Ceremony of the NAFDAC Pharmacist Reserve Group
NAFDAC
NAFDAC inaugurated 600 pharmacists into a voluntary reserve group to enhance regulatory capacity and service delivery.
SMBs in pharmacy and healthcare may benefit from increased regulatory support and faster processing, but should also expect more rigorous inspections.
Address by Prof. Mojisola Christianah Adeyeye at the 49th Annual International Conference of the Chemical Society of Nigeria
NAFDAC
NAFDAC DG highlighted innovations in medicinal and pharmaceutical chemistry for affordable healthcare delivery.
SMBs in pharmaceutical manufacturing and research should note the agency's focus on innovation and affordability, potentially opening opportunities for collaboration.
Regulatory and Supervisory Guidelines for Bureau De Change Operations in Nigeria 2024
Other
New regulatory and supervisory guidelines for Bureau De Change operations in Nigeria were published.
SMBs involved in forex and Bureau De Change operations must comply with updated guidelines, including capital requirements and reporting obligations.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with the Nigerian Export Promotion Council (NEPC) for export purposes.
SMBs in aquaculture and fish farming can leverage this guide to access export markets, but must comply with NEPC registration and export standards.
NAFDAC is intensifying enforcement against non-compliant products and suppliers, increasing supply chain scrutiny.
Mandatory training for clinical trials indicates stricter oversight of research and development activities.
The pharmacist reserve group may lead to more frequent and thorough regulatory inspections.
Blacklisting and watchlisting of specific companies signal the need for robust supplier verification processes.
Focus on innovation and affordable healthcare may create opportunities for SMBs in pharmaceutical R&D.
Bureau De Change guidelines reflect ongoing forex regulatory changes affecting financial SMBs.
NEPC export guide highlights opportunities for agricultural SMBs to expand into export markets.
1
Review and update supplier verification protocols to ensure no dealings with blacklisted entities like Ayrtons Saunders Ltd.
2
Check inventory for products from Mofus Nigeria Ltd and quarantine them pending NAFDAC investigation outcomes.
3
Register staff for the mandatory NAFDAC/NHREC clinical trial training if involved in clinical research.
4
Stay updated on NAFDAC public alerts and watchlists through their official website and newsletters.
5
For Bureau De Change operators, obtain and comply with the 2024 Regulatory and Supervisory Guidelines.
6
For fish farmers, follow NEPC registration steps to access export markets.
7
Consider engaging with NAFDAC's pharmacist reserve group for guidance on regulatory compliance.
8
Conduct internal audits to ensure all products meet NAFDAC standards and are properly registered.